Jeremy Corbyn, Leader of the Labour Party, recently announced a
report entitled "Medicines For the Many: Public Health before
Private Profit", which sets out a proposed set of policies on
access to medicines in the UK, which are reflected in the Labour
Party's manifesto launched last week. An accompanying press
release described the report as "a radical programme of
reforms to make life-changing drugs available at affordable prices
and create a health innovation system that will put public health
before private profit". In this article, we summarise key
aspects of the proposed policies, consider the relevant legal
background and analyse potential implications for companies
operating in the life sciences sector, with a particular focus on
issues relating to intellectual property. We also touch on the
potential for companies which may be affected by the Labour
Party's proposed changes to the sector, to look to public law
and human rights related avenues of challenge, as